Trial intelligence / Profile preview

Immunity Persistence and Booster of Sinovac's Varicella Vaccine

NCT05150392Phase 3Completed

Sponsor
Sinovac Biotech Ltd.
Start
Jul 2018
Primary completion
Aug 2018
Countries
1
01

Overview

A Phase 3 trial of varicella virus vaccine live in varicella (VZV), sponsored by Sinovac Biotech Ltd.. Started Jul 2018; status: completed.

02

Drugs

varicella virus vaccine live
03

Conditions

varicella (VZV)

Beyond the preview

Go deeper on NCT05150392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05150392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call